Tandem Diabetes Care Inc (TNDM)

Currency in USD
12.11
+0.18(+1.51%)
Closed·
12.110.00(0.00%)
·
TNDM Scorecard
Full Analysis
15 analysts have revised their earnings downwards for the upcoming period
TNDM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.6612.20
52 wk Range
9.9847.60
Key Statistics
Prev. Close
11.93
Open
11.8
Day's Range
11.66-12.2
52 wk Range
9.98-47.6
Volume
2.34M
Average Volume (3m)
2M
1-Year Change
-73.25%
Book Value / Share
2
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TNDM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
22.62
Upside
+86.78%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Tandem Diabetes Care Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Tandem Diabetes Care Inc Company Profile

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Tandem Diabetes Care Inc SWOT Analysis


Market Dynamics
Explore Tandem's position in the durable insulin pump market, facing challenges in market share and competitive pressures amid broader industry growth
Innovation Pipeline
Delve into Tandem's product development strategy, including expansion into Type 2 diabetes market and potential impact on future growth prospects
Financial Health
Uncover Tandem's mixed financial performance, with strong revenue growth but profitability challenges, as analysts project varied price targets
Strategic Outlook
Examine Tandem's efforts to overcome growth hurdles, improve margins, and capitalize on new market opportunities in the evolving diabetes care landscape
Read full SWOT analysis

Tandem Diabetes Care Inc Earnings Call Summary for Q2/2025

  • Q2 2025 EPS loss of $0.78, missing forecast by 95%; revenue of $241M slightly above expectations
  • Stock fell 5.02% to $14.39 in after-hours trading, near 52-week low of $13.94
  • Company maintains $1B worldwide sales goal for 2025; $700M US, $300M international
  • Expanding pharmacy channel and international markets; new products planned for 2026
  • Cautious outlook for US market in H2 2025; potential CMS Medicare changes pose minimal concern
Last Updated: 07/08/2025, 08:48
Read Full Transcript

Compare TNDM to Peers and Sector

Metrics to compare
TNDM
Peers
Sector
Relationship
P/E Ratio
−3.9x−4.2x−0.6x
PEG Ratio
0.08−0.140.00
Price/Book
6.0x3.1x2.6x
Price / LTM Sales
0.8x3.0x3.3x
Upside (Analyst Target)
33.3%40.2%37.4%
Fair Value Upside
Unlock2.6%4.5%Unlock

Analyst Ratings

9 Buy
13 Hold
1 Sell
Ratings:
23 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 22.62
(+86.78% Upside)

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
-0.78 / -0.40
Revenue / Forecast
240.68M / 238.57M
EPS Revisions
Last 90 days

TNDM Income Statement

People Also Watch

29.08
CNC
-1.12%
18.06
SRPT
-10.68%
174.15
ALAB
-2.76%
125.24
CRCL
-7.26%
75.90
TEM
-5.74%

FAQ

What Stock Exchange Does Tandem Diabetes Care Trade On?

Tandem Diabetes Care is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Tandem Diabetes Care?

The stock symbol for Tandem Diabetes Care is "TNDM."

What Is the Tandem Diabetes Care Market Cap?

As of today, Tandem Diabetes Care market cap is 815.56M.

What Is Tandem Diabetes Care's Earnings Per Share (TTM)?

The Tandem Diabetes Care EPS (TTM) is -3.10.

When Is the Next Tandem Diabetes Care Earnings Date?

Tandem Diabetes Care will release its next earnings report on 28 Oct 2025.

From a Technical Analysis Perspective, Is TNDM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Tandem Diabetes Care Stock Split?

Tandem Diabetes Care has split 1 times.

How Many Employees Does Tandem Diabetes Care Have?

Tandem Diabetes Care has 2650 employees.

What is the current trading status of Tandem Diabetes Care (TNDM)?

As of 25 Aug 2025, Tandem Diabetes Care (TNDM) is trading at a price of 12.11, with a previous close of 11.93. The stock has fluctuated within a day range of 11.66 to 12.20, while its 52-week range spans from 9.98 to 47.60.

What Is Tandem Diabetes Care (TNDM) Price Target According to Analysts?

The average 12-month price target for Tandem Diabetes Care is USD22.61905, with a high estimate of USD51 and a low estimate of USD11. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +86.78% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.